The DOI matches its Crossref record.
Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor
Abstract
Anticardiolipin antibodies (aCL) found in sera from patients with SLE react with cardiolipin (CL) in the presence of a 50-kDa serum cofactor. The cofactor, which was identified to be beta 2-glycoprotein I by sequencing the N-terminal amino acids, not only enhances CL binding by antibodies in SLE but also depresses it by antibodies associated with syphilis. Cofactor-dependent binding of aCL in SLE to solid phase CL was competitively inhibited by the simultaneous addition of fluid phase CL but was unaffected by either prior or simultaneous addition of a high excess of the cofactor. Binding of aCL in syphilis to solid phase CL was competitively inhibited by either addition of the cofactor or fluid phase CL. aCL in SLE reacted with CL, PS, and PA in the presence of cofactor. In contrast, biotinyl-cofactor bound directly to these anionic phospholipids (PL) and also to PG. These results show that the cofactor-CL complex bears an epitope that confers recognition specificity for aCL in SLE, in contrast with direct CL recognition by syphilitic aCL. The direct binding of the cofactor to PL suggests that the cofactor dependence of aCL binding to PL is due to recognition by aCL of a unique epitope generated upon the formation of the cofactor-CL complex.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Matsuura, E., Igarashi, Y., Yasuda, T., Triplett, D. A., & Koike, T. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.457 · Cited by 529
Self-citationAntiphospholipid antibodies and thrombosis
Greaves, M. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10362-8 · Cited by 309
Blank, M., Krause, I., Fridkin, M., Keller, N., Kopolovic, J., Goldberg, I., Tobar, A., & Shoenfeld, Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci12337 · Cited by 303
Immunology of the antiphospholipid antibody syndrome
Roubey, R. A. S. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390903 · Cited by 302
Blank, M., Krause, I., Fridkin, M., Keller, N., Kopolovic, J., Goldberg, I., Tobar, A., & Shoenfeld, Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0212337 · Cited by 265
Oxidation of LDL and its clinical implication
Matsuura, E., Hughes, G. R. V., & Khamashta, M. A. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.04.018 · Cited by 238
Self-citationMale, C., Foulon, D., Hoogendoorn, H., Vegh, P., Silverman, E., David, M., & Mitchell, L. (2005) · Blood · doi:10.1182/blood-2005-05-2048 · Cited by 106
Franklin, R. D., & Kutteh, W. H. (2002) · Human Reproduction · doi:10.1093/humrep/17.11.2981 · Cited by 92
Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome
Tektonidou, M. G. (2000) · QJM · doi:10.1093/qjmed/93.8.523 · Cited by 80
IgA antiphospholipid antibodies are an independent risk factor for thromboses
Shen, Y., Lee, R., Frenkel, E., & Sarode, R. (2008) · Lupus · doi:10.1177/0961203308093460 · Cited by 39
Pathogenesis of the antiphospholipid syndrome revisited: time to challenge the dogma
Lackner, K. J., & Müller‐Calleja, N. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13320 · Cited by 24
Anticardiolipin antibodies in Jamaican primiparae
Kahwa, E. K., Sargeant, L. A., McCaw-Binns, A., McFarlane-Anderson, N., Smikle, M., Forrester, T., & Wilks, R. (2006) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443610500443352 · Cited by 14
Metadata
- Authors
- Matsuura, E., Igarashi, Y., Fujimoto, M., Ichikawa, K., Suzuki, T., Sumida, T., Yasuda, T., & Koike, T.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1992-06
- Volume
- 148
- Issue
- 12
- Pages
- 3885-3891
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1515034676
- Cited by
- 323
- References
- 0
- FWCI
- 18.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.